| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aadi Bioscience, Inc. | Director | Common Stock | 2,165,998 | $5,198,395 | $2.40 | 04 Mar 2025 | Indirect |
| ViewRay, Inc. | Director | Common Stock | 99,047 | $435,807 | $4.40 | 19 Jul 2023 | Direct |
| Aadi Bioscience, Inc. | Director | Common Stock | 19,694 | $47,266 | $2.40 | 04 Mar 2025 | Direct |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | By KVP Capital, LP |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | Direct |
| Whitehawk Therapeutics, Inc. | Director | Stock Option (right to buy) | 40,006 | 12 Jun 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Stock Option (Right to Buy) | 16,800 | 04 Jun 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Employee Stock Option (Right to Buy) | 0 | 28 Oct 2025 | Direct | ||
| ViewRay, Inc. | Director | Common Stock | 0 | $4.40 | 19 Jul 2023 | Indirect |